NCT05600673

Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata

Efficacy of Combined CO2 Fractional Laser With Bimatoprost 0.03% in Treatment of Alopecia Areata

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Ahmed Hassan Nouh MD · Academic / Other
• Sex: All
• Age: 16 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

The goal of this study is to evaluate the efficacy and safety of combined CO2 fractional laser with Bimatoprost 0.03% as novel treatment of alopecia areata. The main question to study is will the bimatoprost facilitate hair growth if added to fractional CO2 laser treatment in Alopecia areata.

Detailed description

The study included 30 patients who were diagnosed clinically and dermoscopically as alopecia areata with age ranged between 16-55 years. The patients are divided into 2 groups: Group I, received fractional laser sessions with immediate and daily Bimatoprost application and Group II, received only frequent Laser sessions. Laser sessions were given to each patch once every 3 weeks, the procedure was repeated for 3 times.

Conditions

• Alopecia Areata

Interventions

Type	Name	Description
DRUG	Bimatoprost 0.03% solution	Topical Bimatoprost 0.03% solution
DEVICE	CO2 fractional laser	CO2 fractional laser treatment

Timeline

• Start date: 2019-01-01
• Primary completion: 2021-01-30
• Completion: 2021-05-01
• First posted: 2022-10-31
• Last updated: 2022-10-31

Locations

1 site across 1 country: Egypt